Interleukin-2 Recombinant for Cancer from Japan
Aldesleukin, recombinant IL-2 for metastatic renal cell carcinoma immunotherapy. Immunological chemokine under 3002.90.52.50.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Cytokine potency assays
• Lymphokine handling precautions